FEBRUARY 24, 2016 by DAVE MIHALOVIC
HPV Vaccine Rate At Lowest Participation, Dropping More Than 50 Percent Since The Inception of The Program
Vaccination rates are steadily decreasing worldwide, and as more parents now become informed of one of the most unscientific vaccines in the history of vaccination, the HPV vaccine uptake is now dropping more than 50 percent since its introduction in 2006.
Two centuries of UK, USA and Australian official death statistics have shown conclusively and scientifically that modern medicine is not responsible for and played little part in substantially improved life expectancy and survival from disease in western economies.
The fact that many vaccines are ineffective is becoming increasingly apparent. Just a few years ago, Merck was slapped with two separate class action lawsuits contending they lied about the effectiveness of the mumps vaccine in their combination MMR shot, and fabricated efficacy studies to maintain the illusion for the past two decades that the vaccine is highly protective.
A summary review of data on neurological adverse events and the historical role of vaccination in the natural course of infectious disease in Switzerland and Germany, supports data from other regions with evidence that vaccines had no impact on disease prevention efforts from the early-mid to late 20th century.
On the results of analyses of specific outbreaks, some epidemiologists have confirmed on the that out of the cases investigated, that 97 percent of the children were vaccinated.
Convincing evidence has been highlighted in peer reviewed studies showing that the rapid increase in the number of vaccines given to children is creating synergistic toxicity and a state of immune overload in the majority of vaccine recipients manifesting in related health issues including epidemics of obesity, diabetes, and autism.
HPV – A Vaccine Based On Junk Science and Fraud
A publication in the Annals of Medicine has exposed the fraudulent nature of Human papillomavirus (HPV) vaccines such as Gardasil and Cervarix. That’s not a big surprise to most advocates in the natural health community, since no vaccine has ever been fully evaluated in humans to assess long-term health risks. HPV vaccines are no exception.
The problem is, vaccinations such as HPV are not preventative, they do compromise safety and physicians will never provide accurate explanations of vaccine risks and benefits because they do not know themselves. Physicians can only rely on the information from vaccine manufacturers and since long-term pharmacokinetic effects which study the bodily absorption, distribution, metabolism and excretion of vaccines and their ingredients are never examined or analyzed, a Physician can never fully inform of patient of ANY benefits or risks.
In many countries, for a consent to be legally valid if risks and benefits have been explained to the individual. This includes adequate information on which patients can base their decision on whether to accept or refuse a vaccine. In most cases, it requires having a full explanation of the vaccine risks and side-effects.
At present there are no significant data showing that either Gardasil or Cervarix (GlaxoSmithKline) can prevent any type of cervical cancer since the testing period employed was too short to evaluate long-term benefits of HPV vaccination. The longest follow-up data from phase II trials for Gardasil and Cervarix are 5 and 8.4 years, respectively, while invasive cervical cancer takes up to 20 -40 years to develop from the time of acquisition of HPV infection.
Current worldwide HPV immunization practices with either of the two HPV vaccines appear to be neither justified by long-term health benefits nor economically viable, nor is there any evidence that HPV vaccination (even if proven effective against cervical cancer) would reduce the rate of cervical cancer beyond what Pap screening has already achieved.
Cumulatively, the list of serious adverse reactions related to HPV vaccination worldwide includes deaths, convulsions, paraesthesia, paralysis, Guillain-Barre syndrome (GBS), transverse myelitis, facial palsy, chronic fatigue syndrome, anaphylaxis, autoimmune disorders, deep vein thrombosis, pulmonary embolisms, and cervical cancers.
The number of children in private health plans getting vaccinated for HPV is declining by staggering numbers.
Citing low demand, high costs – and questioning the benefits, Utah’s Public Department of Health banned the vaccine. “The backlash and sentiment against it was strong enough that there’s no reason to go there,” physician David Blodgett explained. “No one wants it and it’s too expensive when we’re not funded to provide it.”
At 42 percent, Utah ranks lowest in the nation for completion of the three-injection series among girls who start it. “Some national estimates are showing that HPV vaccination participation has dropped more than 50 percent across the nation since the program was introduced in 2006,” said infectious disease specialist Dr. Alla Anosov.
Decline Continues In HPV Vaccine Completion Rate Thanks To Informed Parents
Thanks to the wealth of information available on the HPV vaccine fraud, the proportion of insured girls and young women completing the human papillomavirus (HPV) vaccine among those who initiated the series has dropped significantly — as much as 63 percent — since the vaccine was approved in 2006, according to new research from the University of Texas Medical Branch (UTMB) in Galveston.
The study, published in Cancer, revealed the steepest decline in vaccine completion among girls and young women aged nine to 18 — the age group according to medical officials that should receive the vaccine in three doses over six months — a message that has been drilled into parents for just over five years. It’s a sign that parents are listening and completing their own research on the dangers of HPV vaccination despite Doctor’s recommendations.
Crippling Adverse Effects
Mercola reports on 213 women who took Gardasil and suffered permanent disability. Multiple-sclerosis-like symptoms and neurological complications, including seizures, paralysis and speech problems, are being reported by increasing numbers of girls and women following Gardasil vaccination
A class-action lawsuit was filed in Australia against drug maker Merck by a young woman who suffered autoimmune and neurological health problems following injections with the HPV vaccine, Gardasil
Between May 2009 and September 2010, 16 deaths occurred after Gardasil vaccination, along with 789 reports of “serious” adverse reactions; 213 cases of permanent disability; and 25 cases of Guillain Barre Syndrome. Between September 1, 2010 and September 15, 2011, yet another 26 deaths were reported.
In 2013, Japan’s health ministry issued a nationwide notice that cervical cancer vaccinations should no longer be recommended for girls due to several hundred adverse reactions to the vaccines reported.
What Are The Facts?
Consider some of the facts related to cervical cancer and the HPV vaccine:
- Cervical cancer is not a major health issue for women under good gynecological care.
- HPV vaccines may protect against four strains of high-risk HPV but the duration of effectiveness is not clear; best estimates to date are from 4 to 6 years
- HPV vaccination does not eliminate the need for traditional cervical cancer screening
- Prior exposure to vaccine-relevant strains of HPV can increase the risk of cancer by 44.6% if injected with Gardasil and 32.5% if injected with Cervarix
- HPV is not transmitted solely via sexual contact, there are multiple other ways to have been exposed
- There are already well over 300 reports to VAERS of abnormal pap smears post-vaccination
- HPV does not cause cervical cancer, it is the persistant infection, not the virus, that determines the risk
- 93% of women initially infected with a particular strain of HPV will not show the same strain four menstrual cycles later
- Most cervical cancer deaths in the United States, and developed countries, are people who are not under regular OB/GYN care.
- The National Cancer Institute has no data on which HPV genotypes are prevalent in the United States.
- A CDC study showed that HPV types 16 and 18, the two HPV vaccine-relevant strains, are NOT the prevalent types in American women.
- Three published papers on HPV prevalence in the U.S., indicated that types 62, 84 and 52 are the most prevalent. None of these are targeted in either approved HPV vaccine, and type 52 is an accepted high-risk “carcinogenic” strain of HPV.
- If a person has prior exposure to vaccine-relevant HPV prior to injection, the vaccine provides no benefit, but does provide potential risks.
- If a woman is infected with HPV-16 in January, HPV-18 in July, and HPV-31 in December, her cancer risk is zero. Even though these are all high risk types, they are considered transient. It takes repeated infection by the same type to perhaps pose a risk of cervical cancer.
- Even when a woman has persistant infection by the same type, if her lifestyle is healthy (she does not smoke, does not take oral contraceptives, does not have multiple sexual partners, does not have a compromised immune system) her risk of cervical cancer is still minimal.
- HPV is not necessarily a sexually transmittable virus–you can get it other ways.
- American women currently spend $10 billion on unnecessary colposcopies (cervical biopsies) every year, primarily because the currently used HPV tests frequently display false positive results.
- A study conducted by Harvard School of Public Health estimated that 95% of cervical biopsies in the United States are not necessary.
- If a young woman is considering taking an HPV vaccine, it is critical that she know if she has been exposed to HPV, and if so, what genotype.
- Nothing has been proven to be more effective at controlling cervical cancer than pap smear technology.
- To date, the efficacy of HPV vaccines in preventing cervical cancer has not been demonstrated, while vaccine risks remain to be fully evaluated.
- Current worldwide HPV vaccination practices with either of the two HPV vaccines appear to be neither justified by long-term health benefits nor economically viable, nor is there any evidence that HPV vaccination (even if proven effective against cervical cancer) would reduce the rate of cervical cancer beyond what Pap screening has already achieved.
- Cumulatively, the list of serious adverse reactions related to HPV vaccination worldwide includes cervical cancer itself.
- The almost exclusive reliance on manufacturers sponsored studies, often of questionable quality, as a base for vaccine policy-making should be discontinued.
- the presentation of partial and non-factual information regarding cervical cancer risks and the usefulness of HPV vaccines, as cited above, is neither scientific nor ethical.
The presentation of partial and non-factual information regarding cervical cancer risks and the usefulness of HPV vaccines, as cited above, is neither scientific nor ethical. None of these practices serve public health interests, nor are they likely to reduce the levels of cervical cancer. Independent evaluation of HPV vaccine safety is urgently needed and should be a priority for government sponsored research programmes. Any future vaccination policies should adhere more rigorously to evidence-based medicine as well as strictly follow ethical guidelines for informed consent.
Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.